Eng

MedAdvisor Solutions' helps pharmacists in Australia deliver more than 115,000 clinical services to patients through Expanded Scope of Practice Pilots in 2024

PR Newswire (美通社)
更新於 10小時前 • 發布於 10小時前 • PR Newswire

New case study showcases improved operational efficiency and patient care with enhanced workflow and clinical services for pharmacists

MELBOURNE, Australia, Jan. 21, 2025 /PRNewswire/ -- MedAdvisor Solutions, a global leader in patient engagement and pharmacy technology, published its newest case study revealing the success of Australia's Expanded Scope of Practice initiative across more than 3,800 pharmacies in the country. The MedAdvisor for Pharmacy platform, used by more than 95% of Australian pharmacies, powers the functionality to support the expanded scope of practice, a government initiative designed to address healthcare workforce shortages and long patient wait times, particularly in rural areas. The case study, Australia's Expanded Scope of Practice: Empowering Pharmacists, Transforming Healthcare, explores why the Australian government launched this initiative back in 2020 and how – with MedAdvisor's technology – it has impacted the healthcare system, highlighting the pivotal role pharmacists play in addressing the nation's care challenges.

廣告(請繼續閱讀本文)

More than 39% of Australians wait more than four weeks to see a general practitioner due to workforce shortage issues1.This leads to treatment delays for patients and overcrowded emergency departments, much of which can be managed through local pharmacies. To lessen this growing strain on the healthcare system, highly trained pharmacists nationwide are starting to provide services for certain acute conditions, like minor ailments and routine medication management. MedAdvisor's case study offers a comprehensive look at how the country's Expanded Scope of Practice initiative is empowering pharmacists to provide these vital care services, reducing the burden on general practitioners and emergency departments while improving access for patients.

Key Highlights from the case study Include:

  • Empowered Pharmacists: Expanded roles allow pharmacists to conduct consultations, prescribe medications, administer vaccines, and manage chronic diseases.

  • Technology-Driven Solutions: MedAdvisor's innovative platforms provide the infrastructure for enhanced patient care and seamless collaboration with providers.

  • Real-World Impact: Success stories from Queensland and New South Wales demonstrate how pharmacists have delivered thousands of consultations and improved health outcomes.

  • The Future of Pharmacy: Insights into how technology and AI will further transform pharmacies into primary healthcare destinations.

"Australia's effort to expand pharmacists' scope of practice gives patients more options and pathways to access services, which ultimately improves the healthcare experience," said Carolyn Clementson, prescribing pharmacist at Good Price Pharmacy Warehouse. "Giving pharmacists these new capabilities further their capacity to engage and interact with patients, providing stronger health outcomes and more satisfaction with the care journey."

廣告(請繼續閱讀本文)

In 2023, the Australian government chose MedAdvisor Solutions as the preferred software for its Expanded Scope of Practice initiative. In the last 12 months more than 115,000 patients are receiving services through this program across more than 3,800 pharmacies. By streamlining administrative tasks and improving workflow efficiency, the company's MedAdvisor for Pharmacy cloud-based, workflow and clinical services platform allows pharmacists to focus on patient care and take on more of these clinical roles. This collaboration is providing patients, pharmacies, and pharmacists with the needed tech and AI-enabled solutions to drive the future of pharmacy, better outcomes and an improved experience for all.
"Today's case study illustrates how critical pharmacists are to primary care delivery and enhancing access to care in Australia," said Rick Ratliff, CEO of MedAdvisor Solutions. "It showcases how pharmacists, supported by cutting-edge technology, are stepping up to meet the growing demands of our healthcare system. At MedAdvisor, we're committed to empowering pharmacists and pharmacies with tools that not only enhance operational efficiency, but also improve patient outcomes."

MedAdvisor's involvement with this initiative underscores the company's role in supporting pharmacists through real-time clinical data, secure communication systems, and tailored solutions. The multi-faceted approach is pivotal as the industry continues to search for innovative ways to lessen strain on the healthcare system and improve patient access to care.

Additional information

廣告(請繼續閱讀本文)

For more detailed information about how prescribing pharmacists see the changes, click here to access our Case Study: Interview with Carolyn Clementson, prescribing pharmacist, Good Price Pharmacy Warehouse.

About MedAdvisor Solutions

MedAdvisor Solutions is a global leader of pharmacy-driven patient engagement solutions that provide individualized patient experiences to simplify the patient medication journey. Our solutions utilise an empathetic, data-driven approach to engagement and an innovative, patient-centric digital experience that empower the pharmacy of the future and inspire lasting behaviour change. MedAdvisor Solutions works with over 37,000 pharmacies across the US, Australia & New Zealand to deliver our solutions to help patients take their medication safely and effectively.

In Australia, MedAdvisor Solutions has connected nearly 4 million patients through more than 95% of Australian pharmacies. MedAdvisor Solutions is on track to become one of the largest players to aid in the global transformation of the pharmacy of the future through digital patient engagement solutions. In 2018 and 2020, MedAdvisor Solutions was recognized in the AFR Fast 100 and in 2022, 2023 and 2024 received the Retail Excellence Award (REX) for Technology & Automation from Drug Store News.

1 OECD (2020), Waiting Times for Health Services: Next in Line, OECD Health Policy Studies, OECD Publishing, Paris

Logo -

查看原始文章

更多 Eng 相關文章

Chinese New Year celebrations launched in Nepal
XINHUA
Metis and the Chartered Insurance Institute (CII) work together to advance industry expertise
PR Newswire (美通社)
The American Chamber of Commerce in Singapore (AmChamSG) Supports Communities in Need Through Donations to SGSHARE and California Wildfires Relief
PR Newswire (美通社)
Update: China concerned as U.S. announces withdrawal from Paris Agreement: spokesperson
XINHUA
The best tiramisu in Singapore, according to Italian chefs
Tatler Hong Kong
Xi talks with Putin via video meeting
XINHUA
Update: China adds 12.56 million new urban jobs in 2024, employment situation stable
XINHUA
Unmanned driving reshapes China's high-altitude mining industry
XINHUA
White House says Trump to withdraw U.S. from Paris climate accord
XINHUA
Update: Trump sworn in as 47th U.S. president
XINHUA
Global Supply Chains Forced to Change Rapidly As World Trade Enters New Era According to Economist Impact and DP World
PR Newswire (美通社)
Economic Watch: German economy contracts for 2nd year amid looming downside risks
XINHUA
dss⁺ Announces Strategic Changes to Executive Leadership Team in Asia Pacific Accelerating growth and impact for high-hazard industries in the region
PR Newswire (美通社)
60"FlyOverChina | Wanfenglin scenic area shrouded in mist
XINHUA
GLOBALink | McKinsey Greater China chairman confident in China's economic prospects
XINHUA
Scenic Danxia landform in NW China
XINHUA
TTA and ISO Join Forces to Revolutionize Global Horticulture and Food Production
PR Newswire (美通社)
LensTalk | Walking through Vienna's winter
XINHUA
Ampace Unveils E30P at Bharat Battery Show: Powering Green Mobility in India
PR Newswire (美通社)
Biden pardons family members before leaving office
XINHUA
Rare Chinese white dolphins spotted in China's Guangxi
XINHUA
Transforming MENA's Energy Landscape: Envision Energy Set to Power Egypt's Gigawatt-Scale Wind Project
PR Newswire (美通社)
TAHO Pharmaceuticals Completes Pivotal Trial of TAH3311, the First Oral Dissolving Film Anticoagulant
PR Newswire (美通社)